Table 1 Association of Bmi-1 expression with patient's clinico-pathological features in ovarian carcinomas
| Â | Â | Bmi-1 protein | ||
|---|---|---|---|---|
| Â | All cases | Low expression | Intensive expression | Pvaluea |
Age at surgery (years) | Â | Â | Â | 0.452 |
≤ 50.7b | 92 | 60 (65%) | 32 (35%) |  |
> 50.7 | 87 | 52 (60%) | 35 (40%) | Â |
Histological type | Â | Â | Â | 0.038 |
Serous (grade 1) | 11 | 9 (82%) | 2 (18%) | Â |
Serous (grade2/3) | 107 | 68 (64%) | 39 (36%) | Â |
Mucinous | 23 | 15 (65%) | 8 (35%) | Â |
Endometrioid | 8 | 7 (88%) | 1 (12%) | Â |
Clear cell | 7 | 5 (71%) | 2 (29%) | Â |
Undifferentiated | 23 | 8 (35%) | 15 (65%) | Â |
Histological grade (Silveberg) | Â | Â | Â | 0.011 |
G1 | 36 | 29 (81%) | 7 (19%) | Â |
G2 | 101 | 63 (62%) | 38 (38%) | Â |
G3 | 42 | 20 (48%) | 22 (52%) | Â |
pT status | Â | Â | Â | 0.037 |
pT1 | 51 | 39 (76%) | 12 (24%) | Â |
pT2 | 35 | 22 (63%) | 13 (37%) | Â |
pT3 | 93 | 51 (55%) | 42 (45%) | Â |
pN status | Â | Â | Â | 0.001 |
pN0 | 88 | 66 (75%) | 22 (25%) | Â |
pN1 | 91 | 46 (51%) | 45 (49%) | Â |
pM status | Â | Â | Â | 0.006 |
pMX | 153 | 102 (67%) | 51 (33%) | Â |
pM1 | 26 | 10 (38%) | 16 (62%) | Â |
FIGO stage | Â | Â | Â | 0.002 |
I | 33 | 27 (82%) | 6 (18%) | Â |
II | 21 | 17 (81%) | 4 (19%) | Â |
III | 99 | 58 (59%) | 41 (41%) | Â |
IV | 26 | 10 38%) | 16 (62%) | Â |